Literature DB >> 22248

Intrapartum fetal asphyxia: clinical characteristics, diagnosis, and significance in relation to pattern of development.

J A Low, S R Pancham, W N Piercy, D Worthington, J Karchmar.   

Abstract

The clinical and fetal heart rates and acid-base characteristics and their sequelae have been reviewed in 587 patients. The relevant clinical factors in the asphyxia group were the preterm fetus, the intrauterine growth retarded fetus, maternal toxemia, and midforceps delivery. The duration of the developing metabolic acidosis in the asphyxia group ranged from terminal to the last two hours of labor. Marked patterns of total decelerations and moderate and marked patterns of late decelerations are of predictive value in the diagnosis of intrapartum fetal asphyxia with a trend to an increased incidence in the longer duration categories, between four and two hours prior to delivery, and a significant increase in all categories during the last two hours of labor. The significance of intrapartum fetal asphyxia to the newborn infant is evident from the low Apgar scores, increased incidence of moderate and severe respiratory distress syndrome, and central nervous system complications in the asphixia group in relation to the normal group.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 22248     DOI: 10.1016/0002-9378(77)90519-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Use of umbilical cord blood gas analysis in the assessment of the newborn.

Authors:  L Armstrong; B J Stenson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-11       Impact factor: 5.747

2.  Fetal heart rate pattern notification guidelines and suggested management algorithm for intrapartum electronic fetal heart rate monitoring.

Authors:  Thomas Downs; Evelyn Zlomke
Journal:  Perm J       Date:  2007

3.  Aetiology of mild mental retardation.

Authors:  M A Lamont; N R Dennis
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.